KEVIN COLEMAN: Open Payments
NPI 1710977871 · RIFLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109 in 6 payments from 4 companies in 2025. Trend: 2023 $200 · 2024 $150 · 2025 $109
Food & beverage: $109
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Astellas Pharma US Inc | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: FARXIGA, Veozah, QULIPTA, EVENITY, BREZTRI.
Industry payments across CO — which companies pay providers there.
